【摘 要】
:
AIM To assess the real-world effectiveness and cost of simeprevir(SMV), and/or sofosbuvir(SOF)-based therapy for chronic hepatitis C virus(HCV) infection.METHOD
【机 构】
:
Division of Liver Diseases, Icahn School of Medicine at Mount Sinai,Janssen Scientific Affairs, LLC,
【出 处】
:
World Journal of Virology